Select region

Device Options in the Cath Lab - Practical Patient Support

The benefits of pre-operative IABP counterpulsation for high risk CABG patients

In this webinar, Dr. Joseph L. Thomas presents his expert opinion, the physiologic basis for pre-operative IABP counterpulsation and the existing clinical data in support of this treatment strategy.

effectiveness of pVADS

What everyone should know about the clinical and economic effectiveness of pVADS

Hospital systems could avoid incremental costs of up to $2.5 billion annually by using IABP as an initial therapy in high-risk PCI and cardiogenic shock patients.

IABP should be implemented as a first-line strategy for cardiogenic shock and high risk PCI.

doctor smiling at patient

Hemodynamic effects of standard vs. larger-capacity intra-aortic balloon counterpulsation pumps

The first reported patient comparison on 40cc vs. 50cc supports our bench test results - 50cc IAB may yield better clinical outcomes than standard 40cc IAB. The 50cc IAB provides:

  • Greater diastolic augmentation and provides greater systolic unloading
  • Significant decrease in cardiac filling pressures and increase of cardiac output

The critical science: Understanding the ABCs of mechanical circulatory support

A review of the physiological principles behind mechanical circulatory support, ranging from inotropes and IABP therapy to (pVADs) and extracorporeal pumps.


The clinical enigma: Randomized trials vs. clinical practice

This discussion addresses points relative to the dichotomy between trial results and clinical practice.


Real world application of mechanical circulatory support

In this discussion, case examples demonstrate how to determine patient selection for mechanical circulatory support.